Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Driving now ...will have to look it over later ...thanks for the link
If only you could PROVE that right??? lol
That's an exciting testament ....thanks Bio
I agree.... and I am not doubtful, I'm just curious of those previous clinical outcomes
Perhaps checking an FDA data bank of new drug/therapy approvals may provide such information under his name as keyword in a search
I have been trying but there is so much to decipher and a lot of it is confusing... i'm still trying to find something
Brian did you happen to dig up any positive results (i.e. FDA approval, drug, immunotherapy) from previous clinical developments during the times he was the PI?
Certainly appreciate your self imposed assurance, but regardless, PMCB is going to be successful. Go KW!!!
Thanks for that link B
it doesn't matter because you said the PI selection would never happen...well guess what? :)
pretty impressive Brian
And it's only 1 o'clock ;)
Well, first, the fall below .02 would certainly be prevented at this point...so, to your thought of a reverse split imo that probably won't happen. I think if KW wanted to attract other/more "big" investors then he would have done that by now...I think with all that's in play KW is doing a fine job with keeping a cool head and a steady hand. The huge increase in volume last week just may very well bring some good news soon.
Can't wait to see who's on those LOI's ....when disclosed, if just one of the LP's is in the top 3 producers then that "particular disclosure" alone will earn Supreme yet another jump in the pps.
We may well be on our way to being the top producer (or one of them), but as a B2B, we need other LP's to do so.
Of course, the LOI's are baked in, but I guarantee you "not fully".
I like knowing that beyond the LOI's and John's ability to make smart connections, that we're about to be a part of something larger than ourselves as we all know that this industry will equate to alcohol and tobacco with HUGE money to be made.
I believe the license, the LOI disclosure, and legalization, these three events themselves, will put us at 2.25 easy with revenues and more strategic connections pushing us up even further.
But then again, big pharma just buy us out as well...KABOOM!!!!!!
Not interested in the technicals for "traders" ...I am waiting for proof of working scientific substance or rather positive test results....GO PMCB!!!!
but hey frosr6......wait for it.....
Uboat, I think it continues to be the biologic matter as KW stated...therein lies the actual constraint of releasing news...imo
I know right?!!! ...lmao
....wait for it.....
lol yeah, The sky is falling!!!...I'm selling all my shares....NOT!!! ... no worries here, CiaB works! ... Bring on the trial!!! :)
Thanks Brian...also, as Rudy highlighted from the previous cc ( other pharmaceutical companies that have approached KW).... the scenario that could very well come to be, imo, is in your article "...[•....developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global pancreatic cancer market./b]..."
lol but it's NOT!!! ...sorry heeheehee
Still no toxic financing....still no T trades....Mgmt. and Fisher still on board.... FDA ODD, EMA ODD, cGMP, patents, CiaB (the best tech), Melligen Cells, Colorado project, Europe project...the outlook remains good....patients, patients, patients....everybody have a great weekend, I am headed out to my tree stand ;)
Great opinion efood...I couldn't agree more.
Immediately following the positive results of the upcoming clinical trial we'll all witness first the curing and complete and utter annihilation of "PMCB Basher Cancer" ;)
....wait for it....
Too bad for you it says ""may"" and not ""will"".....and where is the patent link???
Ok...I was just making sure I understood it correctly...wow, can't wait!!!
But the clinical trial, that KW is trying to get funded, will be what proves that, correct?
Thanks Bio!
Thanks Rudy, I appreciate that.....and LONG indeed!!! :)
Never mind Pete, I just read the difference between cellulose and alginate....sorry. :)
Pete, I see that you also found information on BetaGraft back in May...another competing product. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122858018 ...I just hope we're on the fastest horse.
So, are we in a race?
Attention to this article may have already been previously posted....if so I apologize
I found this interesting... https://www.nih.gov/news-events/nih-research-matters/encapsulated-cells-treat-diabetes-mice
"FREE RIDER" here says go PMCB!!! lol eeeezy efood ... One milestone at a time my friend. :)
"FREE RIDER" here says go PMCB!!! Great find efood ...thanks!
BioNewton and PeacefulWendy get the credit for that post. I just felt the need to repost it. :)
PMCB NOT A SCAM - Proof of PharmaCyte Biotech, Inc.'s legitimacy, product validity, and ongoing development and testing processes:
1-1-14 - KW officially takes over as President of NVLX
1-30-14 - NVLX immediately acquires 14.5% equity interest in Austrianova. First vision
3-20-14 - NVLX contracts with Austrianova to encapsulate cells for clinical trials.
4-1-14 - NVLX selects TD2 to conduct preclinical and clinical studies. i.e. the mice studies-
In 3 shorts months the relationship with Austrianova is solidified and the relationship with TD2 begins.
5-1-14 - NVLX and PMCB begin preclinical studies
7-9-14 - NVLX begins studies for treatment of Ascites Fluid
8-20-14 - TD2 joins NVLX to begin studies showing that CiaB can slow the accumulation of Ascites Fluid.
9-2-14 - NVLX submits application for ODD to EMA.
10-13-14 - NVLX submits application for ODD to FDA.
10-16-14 - NVLX secures world-wide license for Insulin producing cells for Diabetes.
11-24-16 -NVLX forms Diabetes Consortium with Professor Ann Simpson
12-4-14 - NVLX announces opening of Austrianova's cGMP Live Cell Encapsulation Facility.
12-18-14 - First live cell encapsulation at new facility just 14 days after it opens.
12-22-14 - FDA grants ODD to NVLX for Pancreatic Cancer with marketing exclusivity.
This is the end of 2014 and KW has done a ton including setting the base for everything PMCB is doing today. At this time clinical trials have not been scheduled yet.
1-7-15 - NVLX changes name to PharmaCyte Biotech.
2-15-15 - PMCB initiates first preclinical study of encapsulation of cells for Diabetes.
3-18-15 - PMCB finds in addition to everything else CiaB can do it can also consistently shrink tumors.
3-27-15 - PMCB begins talking clinical trial dates.
4-10-15 - Research shows that PMCB's Melligen Cell Line can reverse Diabetes.
4-20-15 - PMCB completes formation of International Diabetes Consortium to cure Diabetes.
5-6-15 - Melligen Cells prove safe in first preclinical test in Vienna.
7-16-15 - PMCB appoints Dr. Manuel Hidalgo to Scientific Advisory Board off of his work with CiaB in the preclinical studies at TD2.
8-15-15 - Interim Audit of cGMP facility is successful.
9-9-15 - PMCB brings Imagining Endpoints on-board to assist in Radiological Imaging for Phase IIB trials
Understand clinical trials could not have started until this last step was completed. As of September, 2014, PMCB was still waiting for cGMP approval for Austrianova's facility
10-21-15 - PMCB and TD2 begin to redesign trial design.
11-17-15 - PMCB obtains ODD from EMA and additional marketing exclusivity.
The year ends without a scheduled clinical trial with at this point a number of things not completed yet.
1-4-16 - KW outlines the rest of 2016 and has been checking off that self imposed list through-out the year. This includes trial set up for late 2016.
1-25-16 - PMCB and TD2 meet to re-design of the trial design.
2-14-16 - PMCB announces that trial still on target for late 2016.
3-31-16 - PMCB and TD2 finalize trial design and is completely re-written.
4-25-16 - cGMP finally granted by Thai Government with full go-ahead. Obviously PMCB has no control over how long it takes a country's government to approve a facility like this. Clinical Trials were never starting until this was done.
Keep in mind that this approval was only granted about 4 months ago and trials are still set for late 2016.
7-14-16 - PMCB receives patent protection of melligen cells to treat Diabetes. Diabetes will begin to play a bigger role once the Phase IIB trial is underway for Pancreatic Cancer.
Collection from BioNewton: At this point today we await the announcement of the Principal Investigator, IND application meeting and then a date for the start of clinical trials. It's easy to blame the CEO for the pps or the needed dilution to get to this point but unfortunately when you have just one product still in clinical trials, dilution is a necessary evil. No way around it. Until CiaB proves itself in humans, it will be difficult to sell another company on it's effectiveness. So, it is do whatever it takes to get to clinical trials. And that is exactly what they are doing. Getting CiaB into clinical trials. Once those results are in, the sky is the limit for PMCB and it's shareholders. The pps is low and well-below almost everyone's cost basis. However, you never lose money until you decide to sell your shares. Be smart. Believe in the Doctors and trust that PMCB is actually in the right hands. There will be value in the pps when PMCB is in trials and then the real value will come when there are buyout rumors and then going into trials for Diabetes. Hold those shares until trials start and begin seeing a gain from your investment. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124700885Pp.............................................................................................................................................................From From Peacefulwendy: PMCB - On target for Phase IIB clinical trial and has destroyed all of the hurdles required to get to this point. Read the breakdown below for the things Ken Waggoner (KW) has completed in just over 2 years. First he had to fix the pile of garbage he was left with. A company with a product and no clue how to get it into trials. That alone takes time. KW made quick work of that and then did all of this leading up to today. The following will show that PMCB is not a scam and it has been moving forward towards clinical trials since KW walked in the door. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125443764